These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11720641)

  • 1. Reasons for non-adherence to antiretroviral therapy: patients' perspectives provide evidence of multiple causes.
    Walsh JC; Horne R; Dalton M; Burgess AP; Gazzard BG
    AIDS Care; 2001 Dec; 13(6):709-20. PubMed ID: 11720641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.
    Barfod TS; Sørensen HT; Nielsen H; Rodkjaer L; Obel N
    HIV Med; 2006 Jul; 7(5):285-90. PubMed ID: 16945072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to highly active antiretroviral therapy (HAAT) at a Federal Medical Centre.
    Shaahu VN; Lawoyin TO; Sangowawa AO
    Afr J Med Med Sci; 2008 Mar; 37(1):29-36. PubMed ID: 18756852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
    Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
    J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exploration of factors influencing adherence to highly active anti-retroviral therapy (HAART) among people living with HIV/AIDS in Northern Thailand.
    Ruanjahn G; Roberts D; Monterosso L
    AIDS Care; 2010 Dec; 22(12):1555-61. PubMed ID: 20582752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home-based study of anti-HIV drug regimen adherence among HIV-infected women: feasibility and preliminary results.
    Durante AJ; Bova CA; Fennie KP; Danvers KA; Holness DR; Burgess JD; Williams AB
    AIDS Care; 2003 Feb; 15(1):103-15. PubMed ID: 12655838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring medication adherence: are missed doses reported more accurately then perfect adherence?
    Wagner GJ; Rabkin JG
    AIDS Care; 2000 Aug; 12(4):405-8. PubMed ID: 11091773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership?
    Kremer H; Bader A; O'Cleirigh C; Bierhoff HW; Brockmeyer NH
    Eur J Med Res; 2004 Feb; 9(2):61-70. PubMed ID: 15090291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia.
    Tadios Y; Davey G
    Ethiop Med J; 2006 Jul; 44(3):237-44. PubMed ID: 17447389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease.
    Schönnesson LN; Williams ML; Ross MW; Diamond PM; Keel B
    Int J STD AIDS; 2007 Jun; 18(6):369-73. PubMed ID: 17609023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV.
    Zorrilla CD; Santiago LE; Knubson D; Liberatore K; Estronza G; Colón O; Acevedo M
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1187-92. PubMed ID: 14983985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating adherence to highly active antiretroviral therapy into children's daily lives: a qualitative study.
    Hammami N; Nöstlinger C; Hoerée T; Lefèvre P; Jonckheer T; Kolsteren P
    Pediatrics; 2004 Nov; 114(5):e591-7. PubMed ID: 15520091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adherence typology: coping, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment.
    Bader A; Kremer H; Erlich-Trungenberger I; Rojas R; Lohmann M; Deobald O; Lochmann R; Altmeyer P; Brockmeyer N
    Med Sci Monit; 2006 Dec; 12(12):CR493-500. PubMed ID: 17136004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study.
    Reynolds NR; Testa MA; Marc LG; Chesney MA; Neidig JL; Smith SR; Vella S; Robbins GK;
    AIDS Behav; 2004 Jun; 8(2):141-50. PubMed ID: 15187476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV antiviral drug resistance: patient comprehension.
    Racey CS; Zhang W; Brandson EK; Fernandes KA; Tzemis D; Harrigan PR; Montaner JS; Barrios R; Toy J; Hogg RS
    AIDS Care; 2010 Jul; 22(7):816-26. PubMed ID: 20635245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factors associated with adherence to therapy among HIV-infected patients in Bangui].
    Mouala C; Kaba-Mebri J; Wata JB; Rey JL
    Sante; 2006; 16(2):119-30. PubMed ID: 17116636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.